These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1767761)

  • 1. [Non-surgical treatment of impotence].
    Otani T
    Hinyokika Kiyo; 1991 Nov; 37(11):1367-72. PubMed ID: 1767761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3 years' experience with intracavernous auto-injection therapy].
    Weiske WH
    Urologe A; 1989 Sep; 28(5):253-6. PubMed ID: 2815435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].
    Arielly J; Weinberg D; Eliraz A; Adam M; el-Hanani BI; Eisenkraft S
    Harefuah; 1994 Apr; 126(7):369-73, 426. PubMed ID: 8200581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining intracavernous injection and external vacuum as treatment for erectile dysfunction.
    Chen J; Godschalk MF; Katz PG; Mulligan T
    J Urol; 1995 May; 153(5):1476-7. PubMed ID: 7714970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracavernous injections of vasoactive drugs. Evaluation of their diagnostic and therapeutic value in 65 cases of erectile impotence].
    Buvat J; Lemaire A; Marcolin G; Dehaene JL; Buvat-Herbaut M
    J Urol (Paris); 1986; 92(2):111-6. PubMed ID: 2876042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracavernous injections of prostaglandin E1 in the treatment of erection disorders].
    Beretta G; Zanollo A; Portalupi W
    Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):481-5. PubMed ID: 1838836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of intracavernous injection of papaverine for erectile impotence].
    Takimoto Y; Kawazoe K; Hosokawa H; Hamada T; Ono M; Aoki Y; Yasuoka S
    Hinyokika Kiyo; 1989 Jan; 35(1):71-6. PubMed ID: 2729023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis.
    Chen RN; Lakin MM; Montague DK; Ausmundson S
    J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
    Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B
    J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
    Ferrière JM; Gaston R; Piechaud T; Le Guillou M
    Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reasons for high drop-out rate with self-injection therapy for impotence.
    Weiss JN; Badlani GH; Ravalli R; Brettschneider N
    Int J Impot Res; 1994 Sep; 6(3):171-4. PubMed ID: 7735362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
    Valdevenito R; Melman A
    Int J Impot Res; 1994 Jun; 6(2):81-91. PubMed ID: 7951702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
    He L; Wen J; Jiang X; Chen H; Tang Y
    Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biweekly intracavernous administration of papaverine for erectile dysfunction.
    Mooradian AD; Morley JE; Kaiser FE; Davis SS; Viosca SP; Korenman SC
    West J Med; 1989 Nov; 151(5):515-7. PubMed ID: 2603417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.